|
|
Volumn 3, Issue , 2011, Pages
|
|
Phase i study of telatinib (BAY 57-9352): Analysis of safety, pharmacokinetics, tumor efficacy, and biomarkers in patients with colorectal cancer
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BAY 60 8246;
BEVACIZUMAB;
CAPECITABINE;
CETUXIMAB;
FLUOROURACIL;
IRINOTECAN;
MITOMYCIN;
OXALIPLATIN;
TELATINIB;
UNCLASSIFIED DRUG;
VASCULOTROPIN RECEPTOR 2;
ADULT;
AGED;
ANOREXIA;
AREA UNDER THE CURVE;
ARTICLE;
ASTHENIA;
CLINICAL ARTICLE;
COLORECTAL CANCER;
COLORECTAL CARCINOMA;
CONTRAST ENHANCEMENT;
DEHYDRATION;
DESQUAMATION;
DIARRHEA;
DIZZINESS;
DRUG DOSE ESCALATION;
DRUG EFFICACY;
DRUG SAFETY;
DRUG TOLERABILITY;
DRUG WITHDRAWAL;
DRY SKIN;
DYSGEUSIA;
DYSPEPSIA;
FATIGUE;
FEMALE;
FLATULENCE;
GASTRITIS;
GASTROINTESTINAL TOXICITY;
HAND FOOT SYNDROME;
HEADACHE;
HEART PALPITATION;
HEARTBURN;
HOARSENESS;
HUMAN;
HYPERTENSION;
INSOMNIA;
LETHARGY;
MALAISE;
MALE;
MAXIMUM PLASMA CONCENTRATION;
MULTICENTER STUDY;
MULTIPLE CYCLE TREATMENT;
MUSCLE WEAKNESS;
MYALGIA;
NAUSEA;
NEUROPATHIC PAIN;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PHARYNGITIS;
PHASE 1 CLINICAL TRIAL;
PRIORITY JOURNAL;
PROTEIN BLOOD LEVEL;
RASH;
SENSORY NEUROPATHY;
SIDE EFFECT;
STOMATITIS;
STRIDOR;
TUMOR BLOOD FLOW;
VOICE CHANGE;
VOMITING;
WEIGHT REDUCTION;
|
|
EID: 84858214931
PISSN: None
EISSN: 2045824X
Source Type: Journal
DOI: 10.1186/2045-824X-3-16 Document Type: Article |
|
Times cited : (12)
|
|
References (5)
|
